Texas Prior Authorization Program Clinical Criteria. Allergen Extracts

Size: px
Start display at page:

Download "Texas Prior Authorization Program Clinical Criteria. Allergen Extracts"

Transcription

1 Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Clinical Information Included in this Document Oralair (Mixed Grass Pollens Allergen Extract)) Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria Prior authorization criteria logic: a description of how the prior authorization request will be evaluated against the clinical criteria rules Logic diagram: a visual depiction of the clinical criteria logic Supporting tables: a collection of information associated with the steps within the criteria (diagnosis codes, procedure codes, and therapy codes) References: clinical publications and sources relevant to this clinical criteria te: Click the hyperlink to navigate directly to that section. Ragwitek (Short Ragweed Pollen Allergen Extract) Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria Prior authorization criteria logic: a description of how the prior authorization request will be evaluated against the clinical criteria rules Logic diagram: a visual depiction of the clinical criteria logic Supporting tables: a collection of information associated with the steps within the criteria (diagnosis codes, procedure codes, and therapy codes) References: clinical publications and sources relevant to this clinical criteria te: Click the hyperlink to navigate directly to that section. vember 9, 2018 Copyright 2018 Health Information Designs, LLC 1

2 Revision tes Removed criteria for Grastek drug is currently not on formulary Removed GCN for Odactra, page 12 vember 9, 2018 Copyright 2018 Health Information Designs, LLC 2

3 Oralair (Grass Pollen Allergen Extract) Drugs Requiring Prior Authorization Oralair Label Name GCN ORALAIR 300 IR SUBLINGUAL TABLET vember 9, 2018 Copyright 2018 Health Information Designs, LLC 3

4 Oralair (Grass Pollen Allergen Extract) Clinical Criteria Logic 1. Is the client greater than or equal to ( ) 10 years of age? [] Go to #2 [] Deny 2. Is the client less than or equal to ( ) 65 years of age? [] Go to #3 [] Deny 3. Does the client have a diagnosis of allergic rhinitis in the last 730 days? [] Go to #4 [] Deny 4. Has the client had hypersensitivity testing in the last 5 years? [] Go to #5 [] - Deny 5. Does the client have 1 claim for auto-injectable epinephrine in the last 365 days or is the patient receiving auto-injectable epinephrine concurrently? [] Go to #6 [] - Deny 6. Does the client have a history of severe, unstable or uncontrolled asthma OR a history of eosinophilic esophagitis in the last 365 days? [] Deny [] Go to #7 7. Does the client have 1 claim for a medication not recommended to be taken in conjunction with Oralair in the last 60 days? [] Deny [] Approve (365 days) vember 9, 2018 Copyright 2018 Health Information Designs, LLC 4

5 Oralair (Grass Pollen Allergen Extract) Clinical Criteria Logic Diagram Step 1 Is the client 10 years of age? Step 2 Is the client 65 years of age? Step 3 Does the client have a diagnosis of allergic rhinitis in the last 730 days? Step 4 Has the client had hypersensitivity testing in the last 5 years? Deny Request Deny Request Deny Request Deny Request Step 5 Does the client have 1 claim for autoinjectable epinephrine in the last 365 days (either previous or concurrent claim)? Deny Request Step 6 Does the client have severe, unstable or uncontrolled asthma or eosinophilic esophagitis in the last 365 days? Deny Request Step 7 Does the client have 1 claim for a contraindicated medication in the last 60 days? Deny Request Approve Request (365 days) vember 9, 2018 Copyright 2018 Health Information Designs, LLC 5

6 Oralair (Grass Pollen Allergen Extract) Clinical Criteria Supporting Tables Step 3 (diagnosis of allergic rhinitis) Look back timeframe: 730 days ICD-10 Code J300 J301 J302 J3089 J309 Description VASOMOTOR RHINITIS ALLERGIC RHINITIS DUE TO POLLEN OTHER SEASONAL ALLERGIC RHINITIS OTHER ALLERGIC RHINITIS ALLERGIC RHINITIS, UNSPECIFIED CPT Code Description Step 4 (hypersensitivity testing) Look back timeframe: 5 years ALLERGEN SPECIFIC IGE; QUANTITATIVE OR SEMIQUANTITATIVE, EACH ALLERGEN ALLERGEN SPECIFIC IGE; QUALITATIVE, MULTIALLERGEN SCREEN TOTAL QUANTITATIVE IGE TOTAL QUALITATIVE IGE PERCUTANEOUS TESTS WITH ALLERGENIC EXTRACTS, IMMEDIATE TYPE REACTION, INCLUDING TEST INTERPRETATION AND REPORT INTRACUTANEOUS (INTRADERMAL) TESTS WITH ALLERGENIC EXTRACTS, IMMEDIATE TYPE REACTION, INCLUDING TEST INTERPRETATION AND REPORT INTRACUTANEOUS (INTRADERMAL) TESTS, SEQUENTIAL AND INCREMENTAL, WITH ALLERGENIC EXTRACTS FOR AIRBORNE ALLERGENS, IMMEDIATE TYPE REACTION, INCLUDING TEST INTERPRETATION AND REPORT INTRACUTANEOUS (INTRADERMAL) TESTS WITH ALLERGENIC EXTRACTS, DELAYED TYPE REACTION, INCLUDING READING vember 9, 2018 Copyright 2018 Health Information Designs, LLC 6

7 Step 5 (history of auto-injectable epinephrine) Look back timeframe: 365 days GCN Description ADRENACLICK 0.15MG AUTO-INJECTOR ADRENACLICK 0.3MG AUTO-INJECTOR AUVI-Q 0.15MG AUTO-INJECTOR AUVI-Q 0.3MG AUTO-INJECTOR EPINEPHRINE 0.15MG AUTO-INJECTOR EPINEPHRINE 0.3MG AUTO-INJECTOR EPIPEN 0.3MG AUTO-INJECTOR EPIPEN JR 0.15MG AUTO-INJECTOR Step 6 (diagnosis of asthma or eosinophilic esophagitis) Look back timeframe: 365 days ICD-10 Code J4520 J4521 J4522 J4530 J4531 J4532 J4540 J4541 J4542 J4550 J4551 J4552 J45901 J45902 J45909 J45990 J45991 J45998 K200 Description MILD INTERMITTENT ASTHMA, UNCOMPLICATED MILD INTERMITTENT ASTHMA WITH (ACUTE) EXACERBATION MILD INTERMITTENT ASTHMA WITH STATUS ASTHMATICUS MILD PERSISTENT ASTHMA, UNCOMPLICATED MILD PERSISTENT ASTHMA WITH (ACUTE) EXACERBATION MILD PERSISTENT ASTHMA WITH STATUS ASTHMATICUS MODERATE PERSISTENT ASTHMA, UNCOMPLICATED MODERATE PERSISTENT ASTHMA, WITH (ACUTE) EXACERBATION MODERATE PERSISTENT ASTHMA, WITH STATUS ASTHMATICUS SEVERE PERSISTENT ASTHMA, UNCOMPLICATED SEVERE PERSISTENT ASTHMA, WITH (ACUTE) EXACERBATION SEVERE PERSISTENT ASTHMA, WITH STATUS ASTHMATICUS UNSPECIFIED ASTHMA, WITH (ACUTE) EXACERBATION UNSPECIFIED ASTHMA, WITH STATUS ASTHMATICUS UNSPECIFIED ASTHMA, UNCOMPLICATED EXERCISE INDUCED BRONCHOSPASM COUGH VARIANT ASTHMA OTHER ASTHMA EOSINOPHILIC ESOPHAGITIS vember 9, 2018 Copyright 2018 Health Information Designs, LLC 7

8 Step 7 (claim for a non-recommended medication) Look back timeframe: 60 days GCN Description ACEBUTOLOL 200MG CAPSULE ACEBUTOLOL 400MG CAPSULE ATENOLOL 100MG TABLET ATENOLOL 25MG TABLET ATENOLOL 50MG TABLET ATENOLOL-CHLORTHAL MG TAB ATENOLOL-CHLORTHAL 50-25MG TAB BETAPACE 120MG TABLET BETAPACE 160MG TABLET BETAPACE 80MG TABLET BETAXOLOL 10MG TABLET BETAXOLOL 20MG TABLET BISOPROLOL FUMARATE 10MG TABLET BISOPROLOL FUMARATE 5MG TABLET BISOPROLOL-HCTZ MG TABLET BISOPROLOL-HCTZ MG TABLET BISOPROLOL-HCTZ MG TABLET BYSTOLIC 10MG TABLET BYSTOLIC 2.5MG TABLET BYSTOLIC 20MG TABLET BYSTOLIC 5MG TABLET CARDURA 1MG TABLET CARDURA 2MG TABLET CARDURA 4MG TABLET CARDURA 8MG TABLET CARVEDILOL 12.5MG TABLET CARVEDILOL 25MG TABLET CARVEDILOL 3.125MG TABLET CARVEDILOL 6.25MG TABLET COREG 12.5MG TABLET COREG 25MG TABLET COREG 3.125MG TABLET COREG 6.25MG TABLET COREG CR 10MG CAPSULE COREG CR 20MG CAPSULE COREG CR 40MG CAPSULE COREG CR 80MG CAPSULE vember 9, 2018 Copyright 2018 Health Information Designs, LLC 8

9 Step 7 (claim for a non-recommended medication) Look back timeframe: 60 days GCN Description CORZIDE 40-5 TABLET CORZIDE 80-5 TABLET D.H.E. 45 1MG/ML AMPULE DIHYDROERGOTAMINE 1MG/ML AMPULE DOXAZOSIN MESYLATE 1MG TABLET DOXAZOSIN MESYLATE 2MG TABLET DOXAZOSIN MESYLATE 4MG TABLET DOXAZOSIN MESYLATE 8MG TABLET DUTOPROL MG TABLET DUTOPROL MG TABLET DUTOPROL MG TABLET ERGOLOID MESYLATES 1MG TABLET HEMANGEOL 4.28MG/ML ORAL SOLN INDERAL LA 120MG CAPSULE INDERAL LA 60MG CAPSULE INDERAL LA 80MG CAPSULE INNOPRAN XL 120MG CAPSULE INNOPRAN XL 80MG CAPSULE LABETALOL HCL 100MG TABLET LABETALOL HCL 200MG TABLET LABETALOL HCL 300MG TABLET LEVATOL 20MG TABLET LOPRESSOR 100MG TABLET LOPRESSOR 50MG TABLET METHERGINE 0.2MG/ML AMPULE METHYLERGONOVINE 0.2MG TABLET METHYLERGONOVINE 0.2MG/ML AMPULE METOPROLOL SUCC ER 100MG TABLET METOPROLOL SUCC ER 200MG TABLET METOPROLOL SUCC ER 25MG TABLET METOPROLOL SUCC ER 50MG TABLET METOPROLOL TARTRATE 100MG TABLET METOPROLOL TARTRATE 25MG TABLET METOPROLOL TARTRATE 50MG TABLET METOPROLOL-HCTZ MG TAB METOPROLOL-HCTZ MG TAB METOPROLOL-HCTZ 50-25MG TAB vember 9, 2018 Copyright 2018 Health Information Designs, LLC 9

10 Step 7 (claim for a non-recommended medication) Look back timeframe: 60 days GCN Description MIGERGOT SUPPOSITORY MINIPRESS 1MG CAPSULE MINIPRESS 2MG CAPSULE MINIPRESS 5MG CAPSULE NADOLOL 20MG TABLET NADOLOL 40MG TABLET NADOLOL 80MG TABLET NADOLOL-BENDROFLU 40-5MG TABLET NADOLOL-BENDROFLU 80-5MG TABLET PINDOLOL 10MG TABLET PINDOLOL 5MG TABLET PRAZOSIN 1MG CAPSULE PRAZOSIN 2MG CAPSULE PRAZOSIN 5MG CAPSULE PROPRANOLOL 10MG TABLET PROPRANOLOL 20MG TABLET PROPRANOLOL 20MG/5ML SOLUTION PROPRANOLOL 40MG/5ML SOLUTION PROPRANOLOL 40MG TABLET PROPRANOLOL 60MG TABLET PROPRANOLOL 80MG TABLET PROPRANOLOL ER 120MG CAPSULE PROPRANOLOL ER 60MG CAPSULE PROPRANOLOL ER 80MG CAPSULE PROPRANOLOL-HCTZ 40-25MG TABLET PROPRANOLOL-HCTZ 80-25MG TABLET SOTALOL 120MG TABLET SOTALOL 160MG TABLET SOTALOL 240MG TABLET SOTALOL 80MG TABLET ZOTYLIZE 5MG/ML ORAL SOLUTION TENORETIC 100 TABLET TENORETIC 50 TABLET TENORMIN 100MG TABLET TENORMIN 25MG TABLET TENORMIN 50MG TABLET TERAZOSIN 10MG CAPSULE vember 9, 2018 Copyright 2018 Health Information Designs, LLC 10

11 Step 7 (claim for a non-recommended medication) Look back timeframe: 60 days GCN Description TERAZOSIN 1MG CAPSULE TERAZOSIN 2MG CAPSULE TERAZOSIN 5MG CAPSULE TIMOLOL MALEATE 10MG TABLET TIMOLOL MALEATE 20MG TABLET TIMOLOL MALEATE 5MG TABLET TOPROL XL 100MG TABLET TOPROL XL 200MG TABLET TOPROL XL 25MG TABLET TOPROL XL 50MG TABLET TRANDATE 100MG TABLET TRANDATE 200MG TABLET TRANDATE 300MG TABLET ZIAC MG TABLET ZIAC MG TABLET ZIAC MG TABLET vember 9, 2018 Copyright 2018 Health Information Designs, LLC 11

12 Ragwitek (Short Ragweed Pollen Allergen Extract) Drugs Requiring Prior Authorization Label Name GCN RAGWITEK SUBLINGUAL TABLET vember 9, 2018 Copyright 2018 Health Information Designs, LLC 12

13 Ragwitek (Short Ragweed Pollen Allergen Extract) Clinical Criteria Logic 1. Is the client greater than or equal to ( ) 18 years of age? [] Go to #2 [] Deny 2. Is the client less than or equal to ( ) 65 years of age? [] Go to #3 [] Deny 3. Does the client have a diagnosis of allergic rhinitis in the last 730 days? [] Go to #4 [] Deny 4. Has the client had hypersensitivity testing in the last 5 years? [] Go to #5 [] Deny 5. Does the client have 1 claim for auto-injectable epinephrine in the last 365 days or is the patient receiving auto-injectable epinephrine concurrently? [] Go to #6 [] - Deny 6. Does the client have a history of severe, unstable or uncontrolled asthma OR a history of eosinophilic esophagitis in the last 365 days? [] Deny [] Go to #7 7. Does the client have 1 claim for a medication not recommended to be taken in conjunction with Ragwitek or Odactra in the last 60 days? [] Deny [] Approve (365 days) vember 9, 2018 Copyright 2018 Health Information Designs, LLC 13

14 Ragwitek (Short Ragweed Pollen Allergen Extract) Clinical Criteria Logic Diagram Step 1 Is the client 18 years of age? Step 2 Is the client 65 years of age? Step 3 Does the client have a diagnosis of allergic rhinitis in the last 730 days? Step 4 Has the client had hypersensitivity testing in the last 5 years? Deny Request Deny Request Deny Request Deny Request Step 5 Does the client have 1 claim for autoinjectable epinephrine in the last 365 days (either previous or concurrent claim)? Deny Request Step 6 Does the client have severe, unstable or uncontrolled asthma or eosinophilic esophagitis in the last 365 days? Deny Request Step 7 Does the client have 1 claim for a contraindicated medication in the last 60 days? Deny Request Approve Request (365 days) vember 9, 2018 Copyright 2018 Health Information Designs, LLC 14

15 Ragwitek (Short Ragweed Pollen Allergen Extract) Clinical Criteria Supporting Tables Step 3 (diagnosis of allergic rhinitis) Look back timeframe: 730 days For the list of allergic rhinitis diagnosis codes that pertain to this step, see the Allergic Rhinitis Diagnoses table in the previous Supporting Tables section. te: Click the hyperlink to navigate directly to the table. Step 4 (hypersensitivity testing) Look back timeframe: 5 years For the list of hypersensitivity testing CPT codes that pertain to this step, see the Hypersensitivity Testing CPT codes table in the previous Supporting Tables section. te: Click the hyperlink to navigate directly to the table. Step 5 (history of auto-injectable epinephrine) Look back timeframe: 180 days For the list of auto-injectable epinephrine GCNs that pertain to this step, see the Auto-Injectable Epinephrine GCNs table in the previous Supporting Tables section. te: Click the hyperlink to navigate directly to the table. Step 6 (diagnosis of asthma or eosinophilic esophagitis) Look back timeframe: 365 days For the list of asthma/eosinophilic esophagitis diagnosis codes that pertain to this step, see the Asthma / Eosinophilic Esophagitis Diagnoses table in the previous Supporting Tables section. te: Click the hyperlink to navigate directly to the table. vember 9, 2018 Copyright 2018 Health Information Designs, LLC 15

16 Step 7 (claim for a non-recommended medication) Look back timeframe: 60 days For the list of non-recommended medication GCNs that pertain to this step, see the n-recommended Medication GCNs table in the previous Supporting Tables section. te: Click the hyperlink to navigate directly to the table. vember 9, 2018 Copyright 2018 Health Information Designs, LLC 16

17 Clinical Criteria References ICD-9-CM Diagnosis Codes, Volume Available at Accessed on July 31, ICD-10-CM Diagnosis Codes, Volume Available at Accessed on July 31, Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma & Immunology. Allergen immunotherapy: A practice parameter third update. JACI 2011;127(1):S1-S55. Available at Accessed January 2, Wallace DV, Dykewicz MS, et al. The diagnosis and management of rhinitis: and updated practice parameter. JACI 2008;122:S1-84. Available at Accessed January 2, Clinical Pharmacology [online database]. Tampa, FL: Elsevier/Gold Standard, Inc.; Available at Accessed on February 23, Micromedex [online database]. Available at Accessed on February 23, Grastek Prescribing Information. ALK-Abello A/S. Horsholm, Denmark. April Oralair Prescribing Information. Greer Laboratories. Lenoir, NC. 9. Ragwitek Prescribing Information. ALK-Abello A/S. Horsholm, Denmark. April Seidman MD, Gurgel RK, Lin SY, et al. Clinical Practice Guideline: Allergic Rhinitis. Otolaryngology Head and Neck Surgery February 2015;152:S1-S Greenhawt M, Oppenheimer J, Nelson M, et al. Sublingual immunotherapy: A focused allergen immunotherapy practice parameter update. Ann Allergy Asthma Immunol 118(2017); vember 9, 2018 Copyright 2018 Health Information Designs, LLC 17

18 Publication History The Publication History records the publication iterations and revisions to this document. tes for the most current revision are also provided in the Revision tes on the first page of this document. Publication Date tes 01/29/2015 Presented to the DUR Board 02/27/2015 Initial publication and posting to website 07/31/2015 Review of ICD-9 and ICD-10 codes 08/01/2018 Annual review by staff Removed ICD-9 codes Updated Table 7, pages 8-11 Added GCN for Odactra, page 17 Updated references, page 22 11/09/2018 Removed criteria for Grastek drug is not currently on formulary Removed GCN for Odactra, page 12 vember 9, 2018 Copyright 2018 Health Information Designs, LLC 18

Texas Prior Authorization Program Clinical Edit Criteria

Texas Prior Authorization Program Clinical Edit Criteria Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

Information for Vermont Prescribers of Prescription Drugs Long Form Bystolic (nebivolol) Tablets

Information for Vermont Prescribers of Prescription Drugs Long Form Bystolic (nebivolol) Tablets Information for Vermont Prescribers of Prescription Drugs Long Form Bystolic (nebivolol) Tablets The prices listed below are Average Wholesale Prices ( AWP ) as established and made available to the public

More information

Sitagliptin (Januvia)

Sitagliptin (Januvia) Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document 25mg Drugs requiring prior authorization: the list of drugs requiring prior

More information

Lidoderm (Lidocaine) Patch

Lidoderm (Lidocaine) Patch Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

Diclofenac 3% Gel, Diclofenac 1.5% and 2% Topical Solution

Diclofenac 3% Gel, Diclofenac 1.5% and 2% Topical Solution Texas Prior Authorization Program Clinical Criteria Drug/Drug Class, Diclofenac 1.5% and 2% Topical Solution This criteria was recommended for review by an MCO to ensure appropriate and safe utilization

More information

Texas Prior Authorization Program Clinical Criteria

Texas Prior Authorization Program Clinical Criteria Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Clinical Criteria Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Oral Immunotherapy Agents Page 1 of 14 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Oral Immunotherapy Agents (Grastek, Oralair, Ragwitek ) Prime Therapeutics

More information

Texas Prior Authorization Program Clinical Edit Criteria

Texas Prior Authorization Program Clinical Edit Criteria Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

Texas Prior Authorization Program Clinical Edit Criteria

Texas Prior Authorization Program Clinical Edit Criteria Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

Ragwitek. Ragwitek (Short Ragweed Pollen Allergen Extract) Description

Ragwitek. Ragwitek (Short Ragweed Pollen Allergen Extract) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.20.05 Subject: Ragwitek Page: 1 of 5 Last Review Date: December 8, 2017 Ragwitek Description Ragwitek

More information

Ragwitek. Ragwitek (Short Ragweed Pollen Allergen Extract) Description

Ragwitek. Ragwitek (Short Ragweed Pollen Allergen Extract) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.08.34 Subject: Ragwitek Page: 1 of 5 Last Review Date: December 3, 2015 Ragwitek Description Ragwitek

More information

Amitiza (Lubiprostone)

Amitiza (Lubiprostone) Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Ragwitek) Reference Number: CP.PMN.83 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial, Medicaid See Important Reminder at the end of this policy for important

More information

Oralair (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract)

Oralair (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Oralair Page: 1 of 5 Last Review Date: November 30, 2018 Oralair Description Oralair (Sweet Vernal,

More information

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Clinical Criteria Information Included in this Document DPP-4 Inhibitor Criteria A: Alogliptin 6.25mg, Januvia 25mg, Nesina 6.25mg, Onglyza

More information

Methylnaltrexone Bromide (Relistor)

Methylnaltrexone Bromide (Relistor) Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

Texas Prior Authorization Program Clinical Criteria

Texas Prior Authorization Program Clinical Criteria Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Clinical Information Included in this Document Xifaxan 200mg Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

Victoza (Liraglutide) Solution for Injection

Victoza (Liraglutide) Solution for Injection Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Oral Immunotherapy Agents Page 1 of 13 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Oral Immunotherapy Agents Prime Therapeutics will review Prior Authorization

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky (Oralair) Reference Number: CP.PMN.85 Effective Date: 11.16.16 Last Review Date: 08.18 Line of Business: Commercial, Medicaid

More information

Texas Prior Authorization Program Clinical Criteria. This criteria was recommended for review by an MCO to ensure appropriate and safe utilization.

Texas Prior Authorization Program Clinical Criteria. This criteria was recommended for review by an MCO to ensure appropriate and safe utilization. Texas Prior Authorization Program Clinical Criteria Drug/Drug Class This criteria was recommended for review by an MCO to ensure appropriate and safe utilization. Clinical Information Included in this

More information

Developed by Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed : October 2009 Most recently updated: September 2011

Developed by Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed : October 2009 Most recently updated: September 2011 Developed by Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed : October 2009 Most recently updated: September 2011 To identify the patients who should receive a beta blocker

More information

Texas Prior Authorization Program Clinical Edit Criteria

Texas Prior Authorization Program Clinical Edit Criteria Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Xifaxan 200mg Drugs requiring prior authorization: the list of drugs requiring

More information

Clinical Policy: Ranolazine (Ranexa) Reference Number: CP.PMN.34 Effective Date: Last Review Date: 02.19

Clinical Policy: Ranolazine (Ranexa) Reference Number: CP.PMN.34 Effective Date: Last Review Date: 02.19 Clinical Policy: (Ranexa) Reference Number: CP.PMN.34 Effective Date: 08.01.09 Last Review Date: 02.19 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important

More information

Texas Prior Authorization Program Clinical Criteria

Texas Prior Authorization Program Clinical Criteria Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Aldurazyme Adagen Carbaglu Ceprotin Elaprase Fabrazyme Lumizyme Naglazyme Orfandin Ravicti Vimizim Note: Click the hyperlink to navigate

More information

Grastek. Grastek (timothy grass pollen allergen extract) Description. Section: Prescription Drugs Effective Date: January 1, 2018

Grastek. Grastek (timothy grass pollen allergen extract) Description. Section: Prescription Drugs Effective Date: January 1, 2018 Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.20.07 Subject: Grastek Page: 1 of 5 Last Review Date: December 8, 2017 Grastek Description Grastek (timothy

More information

Texas Prior Authorization Program Clinical Criteria

Texas Prior Authorization Program Clinical Criteria Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Clinical Criteria Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: House dust mite allergen extract (Odactra) Reference Number: CP.PMN.111 Effective Date: 08.01.17 Last Review Date: 08.18 Line of Business: Commercial, Medicaid Revision Log See Important

More information

Texas Prior Authorization Program Clinical Edit Criteria

Texas Prior Authorization Program Clinical Edit Criteria Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Provigil (Modafinil) Drugs requiring prior authorization: the list of drugs

More information

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

Pharmacy Coverage Guidelines are subject to change as new information becomes available. RAGWITEK (Short Ragweed Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy Coverage Guideline

More information

Agents for the Treatment of Hepatitis C

Agents for the Treatment of Hepatitis C Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Grastek) Reference Number: CP.PMN.84 Effective Date: 11.16.16 Last Review Date: 08.18 Line of Business: Commercial, HIM, Medicaid Revision Log See Important Reminder at the end of this

More information

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association Oral Immunotherapy Agents Page 1 of 15 Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association Title: Oral Immunotherapy Agents (Grastek, Oralair, Ragwitek ) Prime Therapeutics

More information

Injectable Agents for the Treatment of Pulmonary Arterial Hypertension (PAH)

Injectable Agents for the Treatment of Pulmonary Arterial Hypertension (PAH) Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Injectable Agents for the Treatment of Pulmonary Arterial Hypertension (PAH) Clinical Edit Information Included in this Document

More information

The only sublingual grass allergy immunotherapy tablet with a mixed pollens allergen extract from 5 grasses 1

The only sublingual grass allergy immunotherapy tablet with a mixed pollens allergen extract from 5 grasses 1 The only sublingual grass allergy immunotherapy tablet with a mixed pollens allergen extract from 5 grasses 1 An important immunotherapy option for patients with grass allergies Effective during the first

More information

Hypoglycemics, Lantus Insulin

Hypoglycemics, Lantus Insulin Texas Prior Authorization Program PDL Edit Criteria Drug/Drug Class Hypoglycemics, Lantus Insulin Information Included in this Document Hypoglycemics, Lantus Insulin Drugs requiring prior authorization:

More information

The following report contains a description of the request, request specifications, and results from the modular program run(s).

The following report contains a description of the request, request specifications, and results from the modular program run(s). Disclaimer The following report(s) provides findings from an FDA initiated query using Sentinel. While Sentinel queries may be undertaken to assess potential medical product safety risks, they may also

More information

12.5mg, 25mg, 50mg. 25mg, 50mg. 2.5mg, 5mg, 10mg. 5mg, 10mg, 20mg, 100mg. 25mg. -- $2.81 Acetazolamide (IR, 125mg, 250mg, 500mg (ER)

12.5mg, 25mg, 50mg. 25mg, 50mg. 2.5mg, 5mg, 10mg. 5mg, 10mg, 20mg, 100mg. 25mg. -- $2.81 Acetazolamide (IR, 125mg, 250mg, 500mg (ER) MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Blood Pressure P&T DATE: 5/9/2017 THERAPEUTIC CLASS: Cardiovascular Disorders REVIEW HISTORY: 9/15, 2/13, 2/08, 5/07 LOB

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Grastek, Oralair, Ragwitek) Reference Number: CP.CPA.111 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder at the end of

More information

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Combination Agents

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Combination Agents Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Combination Agents This criteria was recommended for review by an MCO to ensure appropriate

More information

Allergy Testing Information

Allergy Testing Information Allergy Testing Information Allergy skin testing takes approximately 1 to 1 ½ hours. Please eat a light breakfast if you are scheduled for a morning appointment. DO NOT SKIP BREAKFAST. If you are scheduled

More information

Beta-Blocker Step Therapy Program

Beta-Blocker Step Therapy Program Beta-Blocker Step Therapy Program Policy Number: 5.01.582 Last Review: 7/2018 Origination: 7/2014 Next Review: 7/2019 LoB: ACA Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage

More information

Fentanyl Agents Clinical Edit Criteria

Fentanyl Agents Clinical Edit Criteria Fentanyl Agents Clinical Edit Criteria Drug/Drug Class: Fentanyl Agents Superior HealthPlan follows the guidance of the Texas Vendor Drug Program (VDP) for all clinical edit criteria. Superior has adjusted

More information

Texas Prior Authorization Program Clinical Edit Criteria

Texas Prior Authorization Program Clinical Edit Criteria Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

IMPORTANT INFORMATION REGARDING YOUR NUCLEAR STRESS TEST

IMPORTANT INFORMATION REGARDING YOUR NUCLEAR STRESS TEST Name: Day One Appointment Day Two Appointment Test Results Appointment Time: Time: Time: IMPORTANT INFORMATION REGARDING YOUR NUCLEAR STRESS TEST A Stress test sometimes also called a treadmill test, helps

More information

Agents for Cystic Fibrosis

Agents for Cystic Fibrosis Texas Prior Authorization Program Clinical Edit Criteria Clinical Edit Information Included in this Document Kalydeco (Ivacaftor) Drugs requiring prior authorization: the list of drugs requiring prior

More information

Texas Prior Authorization Program Clinical Edit Criteria

Texas Prior Authorization Program Clinical Edit Criteria Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Thiazolidinediones Clinical Edit Information Included in this Document Thiazolidinediones Drugs requiring prior authorization: the

More information

UNDERSTANDING ALLERGY IMMUNOTHERAPY

UNDERSTANDING ALLERGY IMMUNOTHERAPY UNDERSTANDING ALLERGY IMMUNOTHERAPY Provide Allergy Patients Another Option for Relief How many of your patients suffer from allergies? ALLERGIES ARE A BURDENSOME CONDITION FOR MANY PEOPLE IN THE US. In

More information

Texas Prior Authorization Program Clinical Edit Criteria

Texas Prior Authorization Program Clinical Edit Criteria Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Aldara 5% Cream Drugs requiring prior authorization: the list of drugs requiring

More information

Texas Prior Authorization Program Clinical Edit Criteria. H.P. Acthar

Texas Prior Authorization Program Clinical Edit Criteria. H.P. Acthar Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

Expert Roundtable on Sublingual Immunotherapy

Expert Roundtable on Sublingual Immunotherapy Expert Roundtable on Sublingual Immunotherapy FACULTY Linda Cox, MD Clinical Associate Professor, Nova Southeastern University Thomas Casale, MD Professor of Medicine, University of South Florida Peter

More information

Authors should appear in this order for PubMed:

Authors should appear in this order for PubMed: 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 Sublingual Immunotherapy: A focused allergen immunotherapy practice parameter update Authors should appear

More information

ACEBUTOLOL HCL 100MG TABLET GENERIC BETA BLOCKERS ALISKIREN 150MG TABLET RASILAZ RENIN INHIBITOR

ACEBUTOLOL HCL 100MG TABLET GENERIC BETA BLOCKERS ALISKIREN 150MG TABLET RASILAZ RENIN INHIBITOR S/N ME OF MEDICATIONS BRANDED/GENERIC DRUG CLASS * UNIT PRICE RANGE (SGD$) 1 ACEBUTOLOL HCL 100MG CAPSULE SECTRAL BETA BLOCKERS 0.50 2 ACEBUTOLOL HCL 100MG TABLET GENERIC BETA BLOCKERS 0.33 3 ALISKIREN

More information

PERSISTENCE OF BETA BLOCKER TREATMENT AFTER A HEART ATTACK

PERSISTENCE OF BETA BLOCKER TREATMENT AFTER A HEART ATTACK PERSISTENCE OF BETA BLOCKER TREATMENT AFTER A HEART ATTACK APPLICATIONS OBJECTIVE Purpose of Measure: ELIGIBLE POPULATION Which members are included? HEDIS (Administrative) NCQA Accreditation (Medicare

More information

Request for Administration of Immunotherapy At an Outside Medical Facility

Request for Administration of Immunotherapy At an Outside Medical Facility Amy L. Darter, M.D. FACAAI, FAAAAI 1810 East Memorial Road, Oklahoma City, OK 73131 (P) 405.607.4333 (F) 405.607.4404 www.okallergy.com Request for Administration of Immunotherapy At an Outside Medical

More information

Value-Based Drug List for ABCs of Diabetes

Value-Based Drug List for ABCs of Diabetes Effective January 1, 2019 Value-Based Drug List for ABCs of Diabetes PCPS provides a Value-Based Benefit Design (VBD) to qualified participants in the ABCs of Diabetes. This means you will have lower out-of-pocket

More information

Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria

Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria Drug/Drug Class Antipsychotics Clinical Criteria Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria Prior

More information

Study Exposures, Outcomes:

Study Exposures, Outcomes: GSK Medicine: Coreg IR, Coreg CR, and InnoPran Study No.: WWE111944/WEUSRTP3149 Title: A nested case-control study of the association between Coreg IR and Coreg CR and hypersensitivity reactions: anaphylactic

More information

ALLERGY PACKET PLEASE READ IMMEDIATELY AND BRING COMPLETED PACKET TO YOUR APPOINTMENT.

ALLERGY PACKET PLEASE READ IMMEDIATELY AND BRING COMPLETED PACKET TO YOUR APPOINTMENT. ALLERGY PACKET PLEASE READ IMMEDIATELY AND BRING COMPLETED PACKET TO YOUR APPOINTMENT. Huntsville Allergy Clinic 927 Franklin Street, Suite 100 Huntsville, AL 35801 256-489-2128 Madison Allergy Clinic

More information

Corporate Medical Policy Allergy Immunotherapy (Desensitization)

Corporate Medical Policy Allergy Immunotherapy (Desensitization) Corporate Medical Policy Allergy Immunotherapy (Desensitization) File Name: Origination: Last CAP Review: Next CAP Review: Last Review: allergy_immunotherapy 7/1979 11/2017 11/2018 11/2017 Description

More information

Flexeril/Amrix (Cyclobenzaprine)

Flexeril/Amrix (Cyclobenzaprine) Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

Allergy Immunotherapy: A New Role for the Family Physician

Allergy Immunotherapy: A New Role for the Family Physician Allergy Immunotherapy: A New Role for the Family Physician Louis Kuritzky MD Clinical Assistant Professor Emeritus Department of Community Health and Family Medicine College of Medicine University of Florida,

More information

100 mg atenolol equivalent to metoprolol

100 mg atenolol equivalent to metoprolol 100 mg atenolol equivalent to metoprolol Metoprolol is a selective beta-blocker at dosages usually prescribed to lower blood. For High Blood Pressure For 7 years I have been on 50 mg. of atenolol for.

More information

12.5mg, 25mg, 50mg. 25mg, 50mg. 250mg, 500mg, 250mg/5ml. 2.5mg, 5mg, 10mg. 5mg, 10mg, 20mg, 100mg. 25mg

12.5mg, 25mg, 50mg. 25mg, 50mg. 250mg, 500mg, 250mg/5ml. 2.5mg, 5mg, 10mg. 5mg, 10mg, 20mg, 100mg. 25mg MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Blood Pressure P&T DATE: 9/11/2018 THERAPEUTIC CLASS: Cardiovascular Disorders REVIEW HISTORY: 5/17, 9/15, 2/13, 2/08, LOB

More information

Flexeril/Amrix (Cyclobenzaprine) Clinical Edit Criteria

Flexeril/Amrix (Cyclobenzaprine) Clinical Edit Criteria Flexeril/Amrix (Cyclobenzaprine) Clinical Edit Criteria Drug/Drug Class: Flexeril/Amrix (Cyclobenzaprine) Superior HealthPlan follows the guidance of the Texas Vendor Drug Program (VDP) for all clinical

More information

ALLERGY TESTING AND TREATMENT

ALLERGY TESTING AND TREATMENT Status Active Medical and Behavioral Health Policy Section: Laboratory Policy Number: VI-02 Effective Date: 03/26/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members

More information

Prior Authorization Neurontin (gabapentin) 2016

Prior Authorization Neurontin (gabapentin) 2016 Drugs Requiring Prior Authorization Label Name GCN GABAPENTIN 100 MG CAPSULE 00780 GABAPENTIN 300 MG CAPSULE 00781 GABAPENTIN 400 MG CAPSULE 00782 GABAPENTIN 250 MG/5 ML SOLN 13235 GABAPENTIN 600 MG TABLET

More information

Sublingual Immunotherapy as a Technique of Allergen Specific Therapy

Sublingual Immunotherapy as a Technique of Allergen Specific Therapy Sublingual Immunotherapy as a Technique of Allergen Specific Therapy Policy Number: 2.01.17 Last Review: 7/2018 Origination: 7/2006 Next Review: 7/2019 Policy Blue Cross and Blue Shield of Kansas City

More information

Oral Agents. Fml Limits. Available Strengths NF NF

Oral Agents. Fml Limits. Available Strengths NF NF MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Allergy Medications LAST REVIEW: 9/12/2017 THERAPEUTIC CLASS: Rheumatologic/Immunologic REVIEW HISTORY: 9/16, 5/15, 9/14

More information

Additional Standard Generics HSA Preventive Drug List Effective January 1, 2019

Additional Standard Generics HSA Preventive Drug List Effective January 1, 2019 Additional Standard Generics HSA Preventive Drug List Effective January 1, 2019 Employers can elect to include an additional generic HSA Preventive Drug coverage feature with your prescription benefit

More information

Texas Prior Authorization Program Clinical Edit Criteria

Texas Prior Authorization Program Clinical Edit Criteria Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document - Oral Drugs requiring prior authorization: the list of drugs requiring prior

More information

ALLERGY TESTING AND ALLERGY IMMUNOTHERAPY

ALLERGY TESTING AND ALLERGY IMMUNOTHERAPY ALLERGY TESTING AND ALLERGY IMMUNOTHERAPY Policy Neighborhood Health Plan reimburses contracted providers for the provision of medically necessary clinically indicated allergy testing and allergy immunotherapy

More information

Preventing and Managing High Blood Pressure

Preventing and Managing High Blood Pressure MINTO PREVENTION & REHABILITATION CENTRE CENTRE DE PREVENTION ET DE READAPTATION MINTO Preventing and Managing High Blood Pressure About This Kit Fortunately, high blood pressure is easily detected and

More information

Drug Regimen Optimization

Drug Regimen Optimization Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Excluding Valsartan / Ramipril Prior authorization criteria logic: a description

More information

ENT SURGICAL CONSULTANTS. LTD Glenwood Avenue, Joliet, Illinois * (815) Office (815) Allergy Dept. (815) Fax

ENT SURGICAL CONSULTANTS. LTD Glenwood Avenue, Joliet, Illinois * (815) Office (815) Allergy Dept. (815) Fax ENT SURGICAL CONSULTANTS. LTD. 2201 Glenwood Avenue, Joliet, Illinois 60435 * (815) 725-1191 Office (815) 531-3804 Allergy Dept. (815) 725-1248 Fax Michael G. Gartlan Rajeev H. Mehta Scott DiVenere Sung

More information

MEDICAL POLICY Allergy Testing & Treatments

MEDICAL POLICY Allergy Testing & Treatments POLICY........ PG-0188 EFFECTIVE......11/30/08 LAST REVIEW... 05/02/17 MEDICAL POLICY Allergy Testing & Treatments GUIDELINES This policy does not certify benefits or authorization of benefits, which is

More information

Drug Regimen Optimization

Drug Regimen Optimization Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Clinical Criteria Information Included in this Document Excluding Valsartan / Ramipril Prior authorization criteria logic: a description

More information

LESSON ASSIGNMENT Given the trade and/or generic name of an adrenergic blocking agent, classify that agent as either an alpha or beta blocker.

LESSON ASSIGNMENT Given the trade and/or generic name of an adrenergic blocking agent, classify that agent as either an alpha or beta blocker. LESSON ASSIGNMENT LESSON 8 Adrenergic Blocking Agents. TEXT ASSIGNMENT Paragraphs 8-1 through 8-5. LESSON OBJECTIVES 8-1. Given a group of statements, select the statement that best describes one of the

More information

Pharmacy Updates Summary

Pharmacy Updates Summary All of the following changes were reviewed and approved by the SFHP Pharmacy & Therapeutics (P&T) Committee on 01/21/2015 Effective date: 02/21/2015 Therapeutic Classes reviewed: Allergen-Specific Immunotherapy

More information

Step Therapy Requirements

Step Therapy Requirements An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 05/01/2018 Updated 4/2018 H0302_2_2014 CMS Accepted 05/05/2014 1 BETA-BLOCKERS BYSTOLIC 10 MG

More information

Assessing the Relative Risks of Subcutaneous and Sublingual Allergen Immunotherapy

Assessing the Relative Risks of Subcutaneous and Sublingual Allergen Immunotherapy Assessing the Relative Risks of Subcutaneous and Sublingual Allergen Immunotherapy Tolly Epstein, MD, MS Assistant Professor of Clinical Medicine Division of Immunology, Allergy & Rheumatology University

More information

AEROALLERGEN IMMUNOTHERAPY FOR ALLERGIC RHINITIS

AEROALLERGEN IMMUNOTHERAPY FOR ALLERGIC RHINITIS AEROALLERGEN IMMUNOTHERAPY FOR ALLERGIC RHINITIS Persia Pourshahnazari MD, FRCPC Clinical Immunology and Allergy November 4, 2018 OBJECTIVES Review indications and evidence for aeroallergen immunotherapy

More information

Comparison of Oral Beta-Blockers

Comparison of Oral Beta-Blockers This Clinical Resource gives subscribers additional insight related to the Recommendations published in March 2017 ~ Resource #330356 Comparison of Oral Beta-Blockers Noncardioselective s (beta-1 and beta-2

More information

Odactra (house dust mite allergen extract) NEW PRODUCT SLIDESHOW

Odactra (house dust mite allergen extract) NEW PRODUCT SLIDESHOW Odactra (house dust mite allergen extract) NEW PRODUCT SLIDESHOW Introduction Brand name: Odactra Generic name: House dust mite allergen extract (Dermatophagoides farinae, Dermatophagoides pteronyssinus)

More information

ODACTRA House Dust Mite (Dermatophagoides farina & Dermatophagoides pteronyssinus) allergen extract sublingual tablet

ODACTRA House Dust Mite (Dermatophagoides farina & Dermatophagoides pteronyssinus) allergen extract sublingual tablet pteronyssinus) allergen extract sublingual tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan.

More information

PRESCRIPTION SAVINGS CLUB FLAT- PRICED GENERIC DRUG LIST (EMDEON) Effective August 20, 2014

PRESCRIPTION SAVINGS CLUB FLAT- PRICED GENERIC DRUG LIST (EMDEON) Effective August 20, 2014 PRESCRIPTION SAVINGS CLUB FLAT- PRICED GENERIC DRUG LIST (EMDEON) Effective August 20, 2014 The Prescription Savings Club provides its members with significant savings on prescription medications. The

More information

RAGWITEK (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use Initial U.S. Approval: 2014

RAGWITEK (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use Initial U.S. Approval: 2014 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RAGWITEK safely and effectively. See full prescribing information for RAGWITEK. RAGWITEK (Short Ragweed

More information

Xyrem (Sodium Oxybate)

Xyrem (Sodium Oxybate) Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Clinical Criteria Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

Texas Prior Authorization Program Clinical Edit Criteria

Texas Prior Authorization Program Clinical Edit Criteria Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

Sublingual Immunotherapy as a Technique of Allergen Specific Therapy

Sublingual Immunotherapy as a Technique of Allergen Specific Therapy Sublingual Immunotherapy as a Technique of Allergen Specific Therapy Policy Number: 2.01.17 Last Review: 7/2014 Origination: 7/2006 Next Review: 7/2015 Policy Blue Cross and Blue Shield of Kansas City

More information

Texas Sinus Center San Antonio La Cantera Pkwy, #20210 San Antonio, TX (210)

Texas Sinus Center San Antonio La Cantera Pkwy, #20210 San Antonio, TX (210) San Antonio 15900 La Cantera Pkwy, #20210 San Antonio, TX 78256 (210) 807-7254 Boerne 34910 IH-10 West, Bldg. 3 Boerne, TX 78006 (830) 816-3838 ALLERGY TESTING INFORMATION 1. On the day of testing please

More information

ASEBP and ARTA TARP Drugs and Reference Price by Categories

ASEBP and ARTA TARP Drugs and Reference Price by Categories ASEBP Pantoprazole Sodium 40 mg (generic) $0.2016 ASEBP Dexlansoprazole 30 mg Dexlansoprazole 60 mg Esomeprazole 10 mg Esomeprazole 20 mg Esomeprazole 40 mg Lansoprazole 15 mg Lansoprazole 30 mg Omeprazole

More information

Additional Standard HSA Preventive Drug List Effective January 1, 2019

Additional Standard HSA Preventive Drug List Effective January 1, 2019 Additional Standard HSA Preventive Drug List Effective January 1, 2019 Employers can elect to include an additional HSA Preventive Drug coverage feature with your prescription benefit plan. Below is the

More information

INVESTIGATIONS & PROCEDURES IN PULMONOLOGY. Immunotherapy in Asthma Dr. Zia Hashim

INVESTIGATIONS & PROCEDURES IN PULMONOLOGY. Immunotherapy in Asthma Dr. Zia Hashim INVESTIGATIONS & PROCEDURES IN PULMONOLOGY Immunotherapy in Asthma Dr. Zia Hashim Definition Involves Administration of gradually increasing quantities of specific allergens to patients with IgE-mediated

More information

South Carolina Department of Health and Human Services Post Office Box 8206 Columbia, South Carolina

South Carolina Department of Health and Human Services Post Office Box 8206 Columbia, South Carolina South Carolina Department of Health and Human Services Post Office Box 8206 Columbia, South Carolina 29202-8206 Pharmacy and Therapeutics (P&T) Committee Meeting MINUTES 1. Call To Order A meeting of the

More information

Jagdeep Hundal, MD, Otolaryngology, Head & Neck Surgery 774 Christiana Rd, Suite B4, Newark, DE Phone: Fax:

Jagdeep Hundal, MD, Otolaryngology, Head & Neck Surgery 774 Christiana Rd, Suite B4, Newark, DE Phone: Fax: Allergy Questionnaire Patient Name Date / / 1. What symptoms do you suffer from? Please circle below Eyes: Itchy eyes, tearing, eye redness, eye discharge Ears: Popping sensation, fullness, itching Nose/Sinus:

More information

Prior Authorization Flexeril/Amrix (cyclobenzaprine) 2017

Prior Authorization Flexeril/Amrix (cyclobenzaprine) 2017 Drugs Requiring Prior Authorization Label Name GCN AMRIX ER 15 MG CAPSULE 97959 AMRIX ER 30 MG CAPSULE 97960 CYCLOBENZAPRINE 10 MG TABLET 18020 CYCLOBENZAPRINE 5 MG TABLET 12805 CYCLOBENZAPRINE 7.5 MG

More information

Cough/Cold Medications

Cough/Cold Medications Texas Prior Authorization Program Clinical Edit Criteria Cough/Cold Medications NOTE: Claims for cough and cold products containing acetaminophen, ibuprofen, or hydrocodone are not covered by Texas Medicaid

More information

Step Therapy Requirements

Step Therapy Requirements An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 12/01/2017 Updated 11/2017 H0302_2_2014 CMS Accepted 05/05/2014 1 ABILIFY Abilify 10 mg tablet

More information